Kim, Y.; Park, K.; Kim, Y.J.; Shin, S.-W.; Kim, Y.J.; Choi, C.; Noh, J.M.
Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model. Int. J. Mol. Sci. 2022, 23, 15539.
https://doi.org/10.3390/ijms232415539
AMA Style
Kim Y, Park K, Kim YJ, Shin S-W, Kim YJ, Choi C, Noh JM.
Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model. International Journal of Molecular Sciences. 2022; 23(24):15539.
https://doi.org/10.3390/ijms232415539
Chicago/Turabian Style
Kim, Yeeun, Kyunghee Park, Yeon Jeong Kim, Sung-Won Shin, Yeon Joo Kim, Changhoon Choi, and Jae Myoung Noh.
2022. "Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model" International Journal of Molecular Sciences 23, no. 24: 15539.
https://doi.org/10.3390/ijms232415539
APA Style
Kim, Y., Park, K., Kim, Y. J., Shin, S. -W., Kim, Y. J., Choi, C., & Noh, J. M.
(2022). Immunomodulation of HDAC Inhibitor Entinostat Potentiates the Anticancer Effects of Radiation and PD-1 Blockade in the Murine Lewis Lung Carcinoma Model. International Journal of Molecular Sciences, 23(24), 15539.
https://doi.org/10.3390/ijms232415539